Zsombor Zrubka
Zsombor Zrubka
E-mail megerősítve itt: uni-corvinus.hu
CímIdézteÉv
Authorized manufacturing changes for therapeutic monoclonal antibodies (mAbs) in European Public Assessment Report (EPAR) documents
B Vezér, Z Buzás, M Sebeszta, Z Zrubka
Current medical research and opinion 32 (5), 829-834, 2016
482016
The economic impact of biosimilars on chronic immune-mediated inflammatory diseases
M Pentek, Z Zrubka, L Gulacsi
Current pharmaceutical design 23 (44), 6770-6778, 2017
72017
Economic aspects of biosimilar competition in Hungary—The treatment of rheumatic disorders
Z Zrubka
Society and Economy 39 (2), 271-290, 2017
32017
A8. 31 Authorised manufacturing changes of therapeutic monoclonal antibodies in EPAR documents
Z Zrubka, B Vezer, M Sebeszta
Annals of the Rheumatic Diseases 74 (Suppl 1), A94-A94, 2015
12015
Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis
L Gulácsi, Z Zrubka, V Brodszky, F Rencz, R Alten, Z Szekanecz, ...
Advances in therapy, 1-25, 2019
2019
PRM171-DETERMINANTS OF THE ACCEPTABILITY OF HEALTH PROBLEMS IN DIFFERENT AGES: EXPLORING A NEW APPLICATION OF THE EQ VAS
Z Zrubka, Z Hermann, L Gulácsi, V Brodszky, F Rencz, M Péntek
Value in Health 21, S385, 2018
2018
PMU124-DOES THE CHOICE OF EQ-5D-3L TARIFF MATTER FOR THE EVALUATION OF CHRONIC DISEASES? COMPARATIVE ANALYSIS OF THE POLISH, UK, SLOVENIAN AND EUROPEAN SCORES
Z Beretzky, Z Zrubka, V Brodszky, F Rencz, L Gulácsi, VP Rupel, D Golicki, ...
Value in Health 21, S328, 2018
2018
PMU90-HEALTH PROBLEMS IN HUNGARIAN ELDERLY OUTPATIENTS MEASURED BY THE EQ-5D-3L: COMPARISON WITH A POPULATION NORM FOR CENTRAL EASTERN EUROPE
Z Zrubka, Z Beretzky, V Brodszky, F Rencz, L Gulácsi, VP Rupel, D Golicki, ...
Value in Health 21, S323, 2018
2018
PMS3-INFLIXIMAB FOR DISEASE-MODIFYING ANTI-RHEUMATIC DRUG-NAIVE RHEUMATOID ARTHRITIS PATIENTS: SYSTEMATIC REVIEW AND DESCRIPTIVE ANALYSIS OF PUBLICATIONS OF RANDOMIZED …
Z Zrubka, V Brodszky, M Péntek, F Rencz, L Gulácsi
Value in Health 21, S288, 2018
2018
PMU126-SUBJECTIVE EXPECTATIONS REGARDING FUTURE HEALTH, WELL-BEING AND HEALTHCARE COSTS IN HUNGARY
Z Beretzky, L Gulácsi, F Rencz, Z Zrubka, V Brodszky, M Péntek
Value in Health 21, S328, 2018
2018
PMU91-USE OF EQ-5D IN CENTRAL AND EASTERN EUROPE 2000-2015: NEUROLOGICAL DISORDERS
VP Rupel, M Divjak, D Golicki, F Rencz, L Gulácsi, V Brodszky, P Baji, ...
Value in Health 21, S323, 2018
2018
EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis
Z Zrubka, F Rencz, J Závada, D Golicki, VP Rupel, J Simon, V Brodszky, ...
Rheumatology international 37 (12), 1957-1977, 2017
2017
Applicability Of The EQ-5D-3L Descriptive System To Explore Subjective Future Health Expectations
M Péntek, V Brodszky, F Rencz, P Baji, Z Zrubka, L Gulácsi
Value in Health 20 (9), A690, 2017
2017
Az informális ellátás mérése és egészség-gazdaságtani értékelése
Z Zrubka
Orvosi Hetilap 158 (35), 1363-1372, 2017
2017
EQ-5D Studies in Rheumatology in Eight Central and Eastern European Countries
M Péntek, F Rencz, D Golicki, VP Rupel, J Simon, V Brodszky, P Baji, ...
Value in Health 19 (7), A542, 2016
2016
Eq-5d Studies In Nervous System Diseases In Eight Central And Eastern European Countries
VP Rupel, E Turk, M Péntek, F Rencz, D Golicki, J Simon, V Brodszky, ...
Value in Health 19 (7), A471, 2016
2016
EQ-5D Studies in Diseases of The Circulatory System in Eight Central and Eastern European Countries
D Golicki, M Péntek, L Gulácsi, VP Rupel, J Simon, V Brodszky, P Baji, ...
Value in Health 19 (7), A657-A658, 2016
2016
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–17